Recent

% | $
Quotes you view appear here for quick access.

Celgene Corporation Message Board

  • theman111knows theman111knows Nov 21, 2012 12:15 PM Flag

    Piper Jaffary "NEAR TERM for SRPT $60-$80 AFTER APPROVAL $160 " **link**

    Street Insider
    Sarepta Therapeutics (SRPT) Jumps on Bullish Comments
    November 21, 2012 9:18 AM EST
    Sarepta Therapeutics, Inc. (NASDAQ: SRPT) is seeing strong pre-open action following positive comments from analysts at Piper Jaffray. The firm said it has the potential to be a $160/share stock but a nearer-term range could be $60-$80/share.

 
CELG
107.95-0.84(-0.77%)Aug 29 4:00 PMEDT